コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
2 cid is classified by the American College of Radiology as a group III gadolinium-based contrast agent (GBCA), which indic
3 Dromaeosaurids (Theropoda: Dromaeosauridae), a group of dynamic, swift predators, have a sparse fossil recor
4 ultiple DMARDs without necessarily benefitting from them; a group of patients variously designated as having 'difficult t
7 es and confidence intervals for each survey measure and age group using the Clopper-Pearson method.
9 TiO(2)(110)) was found to be highly dependent on the anchor group, with Ipa establishing a monolayer much more efficientl
12 nnect, inhibitors bearing two pharmacophores-a zinc binding group and a Cys-reactive warhead-were designed to leverage bo
16 load (PEX group, 8.2 metabolic equivalents +/- 1.7; control group, 11.8 metabolic equivalents +/- 5.5; P < .0001).
18 a chiral mediator, we have developed a transient-directing-group approach to reductive Heck hydroarylation of alkenyl be
19 H, 4pzH, and 4pzH-F2) and functionalized with a dodecanoate group were demonstrated to store thermal energy in their meta
21 complementary ion pairs leading to more complete functional group characterization compared to CAD.
23 ned biopsy was associated with the fewest upgrades to grade group 3 or higher on histopathological analysis of surgical s
25 s, sleep quality was assessed to be better in the melatonin group than that in the placebo group with a mean (SD) of 69.7
29 In multivariable analysis, the Pocket PATH group showed lower risk of nonadherence to lifestyle requirem
30 Patients with PEX achieved a lower maximal workload (PEX group, 8.2 metabolic equivalents +/- 1.7; control group, 11.8
31 was determined that both the bromine atom and the phosphate group were successfully substituted by means of the reaction
32 1 concentration between the tofersen groups and the placebo group was 2 percentage points (95% confidence interval [CI],
33 o be better in the melatonin group than that in the placebo group with a mean (SD) of 69.7 (21.2) and 60.7 (26.3), respec
34 60 (57%) of 104 patients in the placebo group, 63 (66%) of 96 in the ixekizumab Q4W group, and 79 (77
36 2'-butenyloxy, 2'-pentenyloxy, or 2'-methyl-2'-propenyloxy group in the 2-position gave the products of an intramolecula
37 izumab Q4W group, and 79 (77%) of 102 in the ixekizumab Q2W group had at least one treatment-emergent adverse event.
38 in the placebo group, 63 (66%) of 96 in the ixekizumab Q4W group, and 79 (77%) of 102 in the ixekizumab Q2W group had at
39 emonstrate the potential of the 2-sulfonylpyridine reactive group with the discovery of a selective covalent modifier of
41 Seven (2%) of 426 patients in the secukinumab group and six (1%) of 427 patients in the adalimumab group ha
42 dministration to female and male BALB/c mice (10 animal/sex/group) along with their human blood compatibility.
44 phase of GeSe, a structural analogue of layered SnSe (space group: Pnma), has recently attracted attention after a theore
48 ally, machine learning classification algorithms applied to group lasso-selected metabolites were evaluated for classifyi
49 measure called Lag Penalized Weighted Correlation (LPWC) to group pairs of time series that exhibit closely-related behav
50 unaccompanied minors (UAMs) are recognized as a vulnerable group and consequently prioritized by relief efforts.